cladribine has been researched along with Diarrhea in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cubitt, C; Komrokji, RS; Lancet, JE; List, AF; Mirza, AS; Nardelli, L; Padron, E; Pinilla-Ibarz, J; Sweet, K | 1 |
| Braun, JT; Freter, CE; Lionberger, JM; Petruska, PJ; Ramlal, R; Schoen, MW; Woelich, SK | 1 |
| Larson, RA; Mick, R; O'Brien, SM; Ratain, MJ; Spielberger, RT | 1 |
2 trial(s) available for cladribine and Diarrhea
| Article | Year |
|---|---|
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Edema; Female; Granulocyte Colony-Stimulating Factor; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome | 2017 |
Dose-escalation trial of cladribine using five daily intravenous infusions in patients with advanced hematologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Marrow; Chi-Square Distribution; Cladribine; Diarrhea; Digestive System Diseases; Drug Administration Schedule; Fatigue; Female; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Infections; Infusions, Intravenous; Logistic Models; Lymphoproliferative Disorders; Male; Middle Aged; Treatment Outcome | 1996 |
1 other study(ies) available for cladribine and Diarrhea
| Article | Year |
|---|---|
Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Diarrhea; Exanthema; Female; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Male; Middle Aged; Mucositis; Neutropenia; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |